ReviewCurrent cardiology reviews2023
Leadless Pacemakers: State of the Art and Selection of the Ideal Candidate.
Review in Current cardiology reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.
- Pacing-Induced Cardiomyopathy in Leadless and Transvenous Pacemakers: A Meta-Analysis and Meta-Regression.Pacing and clinical electrophysiology : PACE · 2026Pooled it
- Atrial leadless device dislodgment and intracardiac echocardiogram (ICE)-guided device retrieval after leadless pacemaker implantation: A case report.Journal of cardiology cases · 2026Article
- Jugular Journeys: A Novel Approach for AVEIR Leadless Pacemaker Implantation.Pacing and clinical electrophysiology : PACE · 2026Article
- Safety and efficacy of leadless pacemakers: A systematic review and meta-analysis.Heart rhythm O2 · 2026Review
- Association Between Septal Implantation Level and Pacing Threshold Stability in Leadless Pacemaker Implantation.Journal of clinical medicine · 2026Article
- Case Report: Sequential leadless pacing after battery depletion in a patient with recurrent device-related infection.Frontiers in cardiovascular medicine · 2026Article
- Pacemakers in Modern Cardiology and Their Transition From Traditional to Leadless Models.Cureus · 2025Review
- Primary cardiac lymphoma presenting as heart failure and atrioventricular block: case report.Frontiers in oncology · 2025Article
- Association between frailty and in-hospital outcomes in patients undergoing leadless pacemaker implantation: A nationwide analysis.Heart rhythm O2 · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The field of cardiac pacing has been defined by constant development to provide efficacious, safe, and reliable therapy. Traditional pacing utilizes transvenous leads, which dwell in the venous system and place patients at risk for complications, including pneumothorax, bleeding, infection, vascular obstruction, and valvular compromise. Leadless pacemakers have been developed to overcome many of the challenges of transvenous pacing while providing safe and effective pacing therapy for an increasing population of patients. The Medtronic Micra transcatheter pacing system was approved by the FDA in April of 2016 and the Abbott Aveir pacemaker was approved in April of 2022. Several additional leadless pacemakers are in various stages of development and testing. There exists limited guidance on the selection of the ideal candidate for leadless pacemakers. Advantages of leadless pacemakers include decreased infection risk, overcoming limited vascular access, and avoidance of interaction with the tricuspid valve apparatus. Disadvantages of leadless pacemakers include right ventricular-only pacing, unclear lifecycle management, cost, perforation risk, and lack of integration with defibrillator systems. This review aims to provide an overview of the current state of the art of leadless pacemakers, currently approved systems, clinical trials and real-world evidence, considerations for patient selection, and future directions of this promising technology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.